Dexcom, Inc. · NASDAQ:DXCM

Dexcom — Q3 2025 Earnings Presentation

11 slides from Dexcom's earnings presentation, Oct 30, 2025

  1. Slide 1: Dexcom earnings Q3 2025

    bpexcom Dexcom earnings Q3 2025

  2. Slide 2: Safe harbor statement

    Safe harbor statement This presentation contains “forward-looking statements” that are based on our management's beliefs and assumptions and on information available to management as of October 30, 2025. We intend for such forward-looking statements to be covered by the safe harbor provisions for fo

  3. Slide 3: Third quarter 2025 highlights

    Third quarter 2025 idl © Key Financial Strategic $1.209 billion in revenue Highlights Highlights 20% organic revenue! growth over Q3'24 Achieved record quarterly Launched Al-powered meal logging (21% US; 18% INT'L?) earnings per share of $0.61 feature in both the Stelo and Dexcom Surpassed $100 mill

  4. Slide 4: Third quarter performance

    Third quarter performance Total Revenue & Organic Growth Rate”! Non-GAAP Gross Profit and Margin* ($m™) ($MM) $1,500 $900 $1200 $994 $1,114 $1,036 $1,157 $1,209 50 «$626 $661 $596 $696 $741 $900 $600 $600 00 $300 +3% +8% +14% +15% +20% $150 63.0% 59.4% % 60.1% 61.3% $0 $0 Q3'24 Q4'24 Qr2s Q2'25 Q3'2

  5. Slide 5: 2025 Guidance as of October 30, 2025

    2025 Guidance as of October 30, 2025 2025 Annual Revenue and Profitability Guidance Non-GAAP Non-GAAP Adjusted Revenue Gross Profit Margin* Operating Margin* EBITDA Margin*! : USD 5 Previous 4, 600-4625 ~62% ~21% ~30% billion USD Updated — 4, 630-4.650 ~61% 20-21% 29-30% billion 1 See appendix for t

  6. Slide 6: Appendix: Revenue Data and GAAP Reconciliations

    bpexcom Appendix Revenue Data and GAAP Reconciliations

  7. Slide 7: GAAP to non-GAAP reconciliation

    Three Months Ended September 30, Three Months Ended September 30, (In millions) 2025 2024 (In millions, except per share data) 2025 2024 GAAP gross profit $ 731.4 $ 593.8 GAAP net income $ 283.8 $ 134.6 Amortization of intangible assets (1) 7.1 7.1 Amortization of intangible assets (1) 8.0 8.3 Busin

  8. Slide 8: Revenue Metrics By Component

    Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 YTD' 23 YTD' 24 YTD' 25 Revenue Metrics By Component Sensor & Other Revenue (millions) (1) (2) $ 651.9 $ 778.0 $ 873.8 $ 947.0 $ 854.3 $ 947.0 $ 951.8 $ 1,068.5 $ 997.2 $ 1,117.8 $ 1,175.1 $ 2,303.7 $ 2,753.1 $ 3,290.1 Year over year

  9. Slide 9: Revenue Metrics By Geography

    Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 YTD' 23 YTD' 24 YTD' 25 Revenue Metrics By Geography US Revenue (millions) $ 526.0 $ 616.6 $ 713.6 $ 769.1 $ 653.2 $ 731.9 $ 701.9 $ 802.8 $ 750.5 $ 841.0 $ 851.9 $ 1,856.2 $ 2,087.0 $ 2,443.4 Year over year growth 17% 21% 24% 27% 24%

  10. Slide 10: Organic Revenue

    Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 YTD' 23 YTD' 24 YTD' 25 (1) Organic Revenue INT'L Revenue - Reported $ 215.5 $ 254.7 $ 261.4 $ 265.4 $ 267.8 $ 272.4 $ 292.3 $ 310.7 $ 285.5 $ 316.1 $ 357.4 $ 731.6 $ 832.5 $ 959.0 Impact of Acquired Revenue 0.0 0.0 0.0 0.0 0.0 0.0 0.

  11. Slide 11: Non-GAAP definitions

    DexCom, Inc. Amortization of intangible assets - We are required under GAAP to record the fair values of the intangible assets of the entity on our balance sheet and amortize them over their useful lives. We exclude these non-cash amortization charges related to acquired intangible assets from our n

DexCom — Q3 2025 Earnings Presentation on 6ix